Advanced Search

Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2010 September;35(3) > Minerva Endocrinologica 2010 September;35(3):145-51



A Journal on Endocrine System Diseases

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118

Frequency: Quarterly

ISSN 0391-1977

Online ISSN 1827-1634


Minerva Endocrinologica 2010 September;35(3):145-51


Effects of metformin and short-term lifestyle modification on the improvement of male hypogonadism associated with metabolic syndrome

Casulari L. A. 1, Caldas A. D. A. 2, Domingues Casulari Motta L. 3, Lofrano-Porto A. 1,4

1 Section of Endocrinology, University Hospital of Brasília, Faculty of Medicine, University of Brasília, Brasília, DF, Brazil;
2 Department of Endocrinology, Hospital das Forças Armadas, Brasília, DF, Brazil;
3 Department of Obstetrics and Gynecology, University Hospital of Brasília, Faculty of Medicine, University of Brasília
DF, Brazil;
4 Molecular Pharmacology Laboratory, Faculty of Health Sciences, University of Brasilia, Brasilia, DF, Brazil

AIM: The metabolic syndrome is associated with male hypogonadism, but specific studies about the mechanisms and treatment of the testosterone deficit are scanty. The aim of this study was to evaluate the effects of metformin combined with diet and physical activity on the testicular function of men with metabolic syndrome.
METHODS: Thirty-five men (40.4±13.3 years old) with metabolic syndrome were evaluated before and after a four-month period of therapy with metformin 850 mg twice daily, associated with a balanced normocaloric diet and subtle improvement in physical activity. The subjects were divided in two groups: 21 males with normal plasma testosterone levels (≥300 ng/dL) and 14 males with low plasma testosterone levels (<300 ng/dL).
RESULTS: There was a significant decrease in fasting insulin levels and HOMA-IR after treatment (P=0.01 and P=0.06), which was more pronounced in the hypogonadic group (for the effect of absence or presence of hypogonadism, P=0.04). The mean total and free testosterone levels increased significantly after treatment in both groups, similarly. The increase in FSH levels was more pronounced in the hypogonadic group than in the eugonadic group.
CONCLUSION: In this series of males with metabolic syndrome, treatment with metformin associated with healthy dietary modifications and a mild physical activity increment resulted in significant improvement of insulin sensitivity and increase in total and free testosterone levels, regardless of the presence of hypogonadism.

language: English


top of page